Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 838

    1.

    Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

    Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U; WGET Research Group.

    Ann Intern Med. 2007 Nov 6;147(9):611-9.PMID: 17975183 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

    Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.

    Arthritis Rheum. 2000 Sep;43(9):2025-33.PMID: 11014352 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.

    Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.

    Rheumatology (Oxford). 2006 Jun;45(6):724-9. Epub 2006 Jan 6.PMID: 16399845 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

    Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW.

    J Immunol Methods. 2003 Mar 1;274(1-2):27-35.PMID: 12609530 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.

    van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D.

    Clin Exp Immunol. 2002 Sep;129(3):562-70.PMID: 12197900 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.

    Gisslén K, Wieslander J, Westberg G, Herlitz H.

    J Intern Med. 2002 Feb;251(2):129-35.PMID: 11905588 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.

    Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL.

    Ann Intern Med. 1997 Jun 1;126(11):866-73.PMID: 9163287 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

    Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

    Ann Intern Med. 2005 Nov 1;143(9):621-31.PMID: 16263884 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.

    Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J.

    Kidney Int. 1998 May;53(5):1230-6.PMID: 9573537 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.

    Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Tervaert JW.

    Ann Rheum Dis. 2009 Feb;68(2):228-33. Epub 2008 Mar 28.PMID: 18375539 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.

    Damoiseaux JG, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Tervaert JW.

    J Clin Immunol. 2005 May;25(3):202-8.PMID: 15981084 [PubMed - indexed for MEDLINE]Related articles

    14.

    Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?

    Holle JU, Hellmich B, Backes M, Gross WL, Csernok E.

    Ann Rheum Dis. 2005 Dec;64(12):1773-9. Epub 2005 Apr 20.PMID: 15843447 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.

    Muller Kobold AC, Kallenberg CG, Tervaert JW.

    Br J Rheumatol. 1998 Aug;37(8):901-7.PMID: 9734683 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.

    Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL.

    Rheumatology (Oxford). 2004 Feb;43(2):174-80. Epub 2003 Oct 29.PMID: 14585921 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.

    Villalta D, Tonutti E, Tampoia M, Bizzaro N, Papisch W, Tozzoli R, Stella S.

    Clin Chem Lab Med. 2004;42(10):1161-7.PMID: 15552276 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.

    Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R.

    Clin Exp Immunol. 1993 Sep;93(3):405-10.PMID: 8370167 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data